Cargando…

Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19

Detalles Bibliográficos
Autores principales:	Mina, Michael J, Peto, Tim E, García-Fiñana, Marta, Semple, Malcolm G, Buchan, Iain E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049601/ https://www.ncbi.nlm.nih.gov/pubmed/33609444 http://dx.doi.org/10.1016/S0140-6736(21)00425-6

Ejemplares similares

Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study
por: García-Fiñana, Marta, et al.
Publicado: (2021)

SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission
por: Fearon, Elizabeth, et al.
Publicado: (2021)

Association of SARS-CoV-2 viral load distributions with individual demographics and suspected variant type: results from the Liverpool community testing pilot, England, 6 November 2020 to 8 September 2021
por: Hughes, David M, et al.
Publicado: (2023)

Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of Liverpool, UK (November 2020 to January 2021)
por: Green, Mark A., et al.
Publicado: (2021)

Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
por: Singh, Dave, et al.
Publicado: (2020)

COV-BOOST: evidence to support rapid booster deployment
por: Hall, Victoria, et al.
Publicado: (2021)

Impact of community asymptomatic rapid antigen testing on covid-19 related hospital admissions: synthetic control study
por: Zhang, Xingna, et al.
Publicado: (2022)

Clarifying methodological misunderstandings regarding estimates of excess mortality associated with elevated body weight
por: Ward, Zachary J., et al.
Publicado: (2022)

Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: a cohort analysis of 2.7 M people
por: Green, Mark A., et al.
Publicado: (2022)

Rapid antigen testing in COVID-19 management for school-aged children: an observational study in Cheshire and Merseyside, UK
por: Hughes, David M, et al.
Publicado: (2022)

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
por: Markov, Peter V., et al.
Publicado: (2022)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

Credibility and evidence in the handling of SARS-CoV-2
por: Velilla-Jiménez, Helbert E.
Publicado: (2021)

Recalibrating SARS-CoV-2 Antigen Rapid Lateral Flow Test Relative Sensitivity from Validation Studies to Absolute Sensitivity for Indicating Individuals Shedding Transmissible Virus
por: Petersen, Irene, et al.
Publicado: (2021)

Need for clarifying remote physiologic monitoring reimbursement during the COVID-19 pandemic: a respiratory disease case study
por: Jarrin, Robert, et al.
Publicado: (2021)

SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings
por: Boehme, Catharina, et al.
Publicado: (2021)

Serial antigen rapid testing in staff of a large acute hospital
por: Wu, Sean, et al.
Publicado: (2022)

Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response time
por: Vickers, Claudia E., et al.
Publicado: (2022)

Rolling out COVID-19 antigen rapid diagnostic tests: the time is now
por: Peeling, Rosanna W, et al.
Publicado: (2021)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing
por: Peto, Tim
Publicado: (2021)

Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection
por: Talarico, Rosaria, et al.
Publicado: (2020)

Daily testing of contacts of SARS-CoV-2 infected cases as an alternative to quarantine for key workers in Liverpool: A prospective cohort study
por: Marsden, Lucy, et al.
Publicado: (2022)

COVID-19 rapid antigen testing strategies must be evaluated in intended use settings
por: Dinnes, Jacqueline, et al.
Publicado: (2022)

Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials
por: Moran, Ed, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2
por: Pitzer, Virginia E, et al.
Publicado: (2020)

A genomics network established to respond rapidly to public health threats in South Africa
por: Msomi, Nokukhanya, et al.
Publicado: (2020)

Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
por: Brightling, Christopher E, et al.
Publicado: (2022)

Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Sustainability of surveillance systems for SARS-CoV-2
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ruhc0ka53pvgtatpud97jg0qgr